What is MapLight Therapeutics, Inc. 's operating cash flow?

MapLight Therapeutics, Inc. (MPLT) reported operating cash flow of -$51.18M in Q1 2026.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

MapLight Therapeutics, Inc. MPLT Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers SquibbBMY

$1.1B-43.5%

Johnson & JohnsonJNJ

$2.51B-39.8%

Neurocrine BiosciencesNBIX

$145.8M+125%

Acadia PharmaceuticalsACAD

$33.98M+67.2%

AbbVieABBV

$3.83B+134%

LBR

LB Pharmaceuticals Inc Common StockLBRX

-$23.29M-187%

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B—

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's operating cash flow?: MapLight Therapeutics, Inc. (MPLT) reported operating cash flow of -$51.18M in Q1 2026.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.